Trial Profile
A trial to compare the effects of ramosetron and ondansetron in spinal anesthesia induced adverse effects.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Jun 2016
Price :
$35
*
At a glance
- Drugs Ondansetron (Primary) ; Ramosetron (Primary)
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- 17 Jun 2016 New trial record